MedX Health Corp Completes Final Closing of $2.8 Million Private Placement
MedX Health Corp. (TSX-V: MDX) has announced the final closing of its non-brokered private placement of Series IV Convertible Loan Notes to accredited investors. This closing follows an initial announcement in February 2026 and an extension request in April 2026. The total amount raised through this placement is $2,800,000. This figure includes $2,400,000 from the surrender of existing Series I Convertible Loan Notes by holders and $400,000 from new subscriptions, comprising an initial $300,000 and a subsequent $100,000 closing. The Series IV Notes carry an annual interest rate of 6%, payable quarterly, and mature on December 31, 2028. Holders may convert these notes into units at $0.10 per unit until maturity, with each unit consisting of one common share and half a share purchase warrant. Certain company insiders participated in the placement, which was conducted under exemptions from formal valuation requirements. The raised funds are designated for replacing Series I Notes, further developing the company’s SIAscopy® and DermSecure® telemedicine platforms, expanding into the occupational health market, and general corporate purposes.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page itself is projected from evidence records.
- Current automated evidence projection